See also
ˇ Show More
You have visited 10 password protected pages for free. Others contain data covered by 
.
Sign Up Now to get full access to whole website and cut out all advertisements.
Eli Lilly & Co., Common-Size Consolidated Income Statement
| Dec 31, 2010 | Dec 31, 2009 | Dec 31, 2008 | Dec 31, 2007 | Dec 31, 2006 | ||
|---|---|---|---|---|---|---|
 |
Revenue | |
|
|
|
|
|
Cost of sales | |
|
|
|
|
|
Gross profit | % |
% |
% |
% |
% |
|
Research and development | |
|
|
|
|
|
Marketing, selling, and administrative | |
|
|
|
|
|
Acquired in-process research and development | |
|
|
|
|
|
Asset impairments, restructuring, and other special charges | |
|
|
|
|
|
Operating income (loss) | % |
% |
% |
% |
% |
|
Interest expense | |
|
|
|
|
|
Interest income | |
|
|
|
|
|
Other income (expense) | |
|
|
|
|
|
Other expense, net | % |
% |
% |
% |
% |
|
Income (loss) before income taxes | % |
% |
% |
% |
% |
|
Income taxes | |
|
|
|
|
|
Net income (loss) | % |
% |
% |
% |
% |
February 8, 2012